DeepIntent’s Patient Modeled Audiences Solution Uses Industry’s Most Comprehensive Real-World Clinical Datasets to Precisely Reach Patient Populations, Including Those Facing Rare Diseases and Low …
What trends can healthcare marketers expect in 2022? In this article for Endpoints News, CEO Chris Paquette discusses how pharma brands will be increasing …
NEW YORK, Dec. 13, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, …
Artificial intelligence and machine learning technology are revolutionizing the healthcare industry right before our very eyes. In this article for AiThority.com, CEO Chris Paquette …
DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant. In this article, Pharmaceutical …
When pharma ads are relevant, they drive patient action. In this article, Endpoints News highlights the findings from DeepIntent’s research study on patient attitudes …
As linear TV viewership continues its decline, pharma marketers will need to adjust their strategies to reach healthcare audiences on all screens. In this …
NEW YORK, Oct. 27, 2021 — DeepIntent, the leading independent healthcare marketing technology company built purposefully to influence patient health and business outcomes, today …
